VYNE Therapeutics Investor Presentation April 2022

VYNE Therapeutics is a biopharmaceutical company developing proprietary therapies for immuno-inflammatory conditions and rare skin diseases. The company's pipeline focuses on JAK/sphingosine-1 receptor modulator combinations and BET inhibitors, with near-term clinical catalysts expected for lead programs FMX114, VYN201, and VYN202.